Dementia, Restraints, and the Regs

June 19, 2026, from 2:00 PM - 3:00 PM HST

COURSE DESCRIPTION | LEARNING OBJECTIVES | TARGET AUDIENCE | SPEAKER | COST | CONTINUING EDUCATION | REGISTRATION

Providing care to those living with dementia in nursing facility settings can be complex and rewarding. Having an understanding of various approaches to deal with challenging behaviors is important and impactful to the resident's quality of life.

Best practice standards indicate that dementia behaviors should be managed without the use of physical or chemical restraints; however, when they are deemed necessary staff members must have knowledge of current CMS regulations and documentation requirements. The interdisciplinary team must make efforts to reduce psychotropic drug use as appropriate and provide compassionate and person-centered care in compliance with regulatory standards.

Join us as we examine strategies to manage challenging behaviors from those living with dementia and discuss physical and chemical restraints, documentation standards, interdisciplinary approaches, and maintaining quality of life in accordance with regulatory compliance.

This webinar will be recorded and made available on the HAH website for on-demand viewing.

1. Define and describe consequences of physical and chemical restraints
2. Identify strategies to mitigate physical restraint use
3. Describe CMS regulatory requirements related to psychotropic drug use
4. Explore how to apply practice strategies to facilitate the reduction of psychotropic drug use

Interdisciplinary team members working in post-acute and long-term care settings

Registration includes access to on-demand content.

HAH Member: FREE

Non-Member: FREE

Are you an employee of an HAH member organization and qualify for the member rate? CLICK HERE to find out!

*No cancellations or refunds as content will be available on-demand.

To be eligible for a CE certificate each person must register for the series, pay the registration fee (if applicable), attend the session via the webinar software on your computer or via the GoTo Webinar™ mobile app, and complete the corresponding HAH evaluation. Phone only attendance is not tracked.

Valid for the live webinar and on-demand recording through 06/19/2028: This nursing continuing professional development activity is pending approval by Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

State licensure boards have final authority on the acceptance of individual courses. Aida Wen, MD, CMD, is a stockholder with Pfizer, a publicly traded company. The relevant financial relationship has been mitigated. No relevant financial relationships were identified for any other individuals with the ability to control content of this activity.